Adiponectin, ALT and Family History As Critical Markers for the Development of Type 2 Diabetes in Obese Japanese Children
Overview
Affiliations
Aims/introduction: An association between the pathogenesis of type 2 diabetes mellitus (T2D) and that of metabolic syndrome (MS) in obese children has been suggested. We clarified the critical markers for the development of T2D in obese Japanese children.
Methods: One hundred and seven obese children who visited our outpatient clinic were enrolled in this study. The obese subjects were divided into 3 groups: Group A, T2D (n = 19); Group B, MS but not T2D (n = 19); and Group C: non-T2D, non-MS (n = 69). In all the subjects, a biochemical examination was performed and the serum adiponectin and leptin levels were measured. Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were measured using computed tomography images.
Results: Group A tended to have higher VAT values and VAT/SAT ratios and lower leptin and adiponectin levels, compared with Groups B and C. In Group A, the alanine aminotransferase (ALT) level was significantly higher and the aspartate aminotransferase (AST)/ALT ratio was significantly lower than in Group C. A receiver operating characteristic (ROC) analysis showed that the optimal cut-off point for adiponectin was 6.4 μg/mL (AUC = 0.859). The cut-off points for ALT, the AST/ALT ratio and VAT were 35 IU/L (AUC = 0.821), 0.85 (AUC = 0.794) and 78 cm (AUC = 0.713), respectively. Group A had a significantly higher frequency of a family history of T2D than Group B.
Conclusions: Our study revealed that the adiponectin level, ALT level, AST/ALT ratio, VAT value and a family history of T2D may be critical characteristic markers for T2D among obese Japanese children.
Uric acid is associated with type 2 diabetes: data mining approaches.
Mansoori A, Tanbakuchi D, Fallahi Z, Rezae F, Vahabzadeh R, Saffar Soflaei S Diabetol Int. 2024; 15(3):518-527.
PMID: 39101191 PMC: 11291799. DOI: 10.1007/s13340-024-00701-0.
Emamian A, Emamian M, Hashemi H, Fotouhi A Sci Rep. 2024; 14(1):9390.
PMID: 38658745 PMC: 11043380. DOI: 10.1038/s41598-024-60092-9.
Wu Z, Chi S, Ouyang L, Xu X, Chen J, Jin B World J Pediatr. 2024; 20(9):949-956.
PMID: 38388968 DOI: 10.1007/s12519-023-00789-5.
Akash M, Shahid M, Suhail S, Rehman K, Nadeem A, Mir T Front Endocrinol (Lausanne). 2023; 14:1240291.
PMID: 37693342 PMC: 10485609. DOI: 10.3389/fendo.2023.1240291.
Sun X, Qiu W, Wu J, Ding S, Wu R J Clin Lab Anal. 2023; 37(6):e24875.
PMID: 37003602 PMC: 10156094. DOI: 10.1002/jcla.24875.